115 related articles for article (PubMed ID: 27255021)
1. [Bowel obstruction-induced cholinergic crisis with progressive respiratory failure following distigmine bromide treatment].
Kobayashi K; Sekiguchi H; Sato N; Hirose Y
Chudoku Kenkyu; 2016 Mar; 29(1):26-9. PubMed ID: 27255021
[TBL] [Abstract][Full Text] [Related]
2. [Three cases of cholinergic crisis in which serum distigmine bromide concentrations were measured].
Onodera M; Fujino Y; Inoue Y; Endo S; Fujita Y
Chudoku Kenkyu; 2008 Jan; 21(1):75-81. PubMed ID: 18277557
[TBL] [Abstract][Full Text] [Related]
3. [Cholinergic crisis following administration of distigmine bromide: a case report].
Yamanaka S; Fujita I; Murota T; Kawakita M; Matsuda T
Hinyokika Kiyo; 2002 Jan; 48(1):21-3. PubMed ID: 11868380
[TBL] [Abstract][Full Text] [Related]
4. [Acute respiratory failure associated with cholinergic crisis: report of five cases and review of the literature].
Takahashi M; Ubukata S; Sato E; Shoji M; Morikawa N; Watanabe H; Takahashi H
Nihon Kokyuki Gakkai Zasshi; 2011 Dec; 49(12):877-84. PubMed ID: 22352046
[TBL] [Abstract][Full Text] [Related]
5. [A case of acute distigmine bromide intoxication in the therapeutic dosage for treatment of underactive neurogenic bladder].
Tada M; Fujita N; Umeda M; Koike H; Nagai H
No To Shinkei; 2004 May; 56(5):415-9. PubMed ID: 15279199
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic Crisis Owing to Distigmine Bromide Complicated by Hyperosmolar Hyperglycemic State.
Kotake K; Tone A; Watanabe S; Senoo M; Kaneto M; Imai Y; Teshigawara S; Kawakami Y; Nakatou T
Intern Med; 2021 Jul; 60(14):2251-2254. PubMed ID: 33583891
[TBL] [Abstract][Full Text] [Related]
7. Unexpected cholinergic crisis caused by distigmine bromide: A case report.
Sera T; Kusunoki S; Shime N
Medicine (Baltimore); 2022 Nov; 101(47):e31677. PubMed ID: 36451415
[TBL] [Abstract][Full Text] [Related]
8. Absolute bioavailability, pharmacokinetics, renal and biliary clearance of distigmine after a single oral dose in comparison to i.v. administration of 14C-distigmine-bromide in healthy volunteers.
Vree TB; Waitzinger J; Hammermaier A; Radhofer-Welte S
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):393-403. PubMed ID: 10475142
[TBL] [Abstract][Full Text] [Related]
9. [Patients confined in bed for an extended period and developing cholinergic crisis following administration of distigmine bromide: report of 3 cases].
Tadara R; Kobayashi M; Nakamura N; Suzuki Y; Isono S
Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1566-7. PubMed ID: 9780688
[No Abstract] [Full Text] [Related]
10. Cholinergic crisis following treatment of postoperative urinary retention with distigmine bromide.
Hameed A; Charles TJ
Br J Clin Pract; 1994; 48(2):103-4. PubMed ID: 7912951
[TBL] [Abstract][Full Text] [Related]
11. Effect of Patient Age, Dose, and Chronic Kidney Disease on the Risk of Adverse Reactions to Distigmine.
Mitsuboshi S; Nagai K; Okajima H
Biol Pharm Bull; 2020; 43(8):1275-1278. PubMed ID: 32741950
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between cholinergic symptoms caused by distigmine and the activities of serum AChE and BChE].
Koga M; Miyata H; Tsuno N; Nakayama K; Ushijima S; Tanaka Y; Hiraga Y; Kobayashi N
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Jun; 17(3):143-7. PubMed ID: 9278940
[TBL] [Abstract][Full Text] [Related]
13. [Distigmine bromide induced Parkinsonism. A case report].
Sato S; Nakamura K; Nakahara T; Yamamoto T
Rinsho Shinkeigaku; 2005 Aug; 45(8):600-2. PubMed ID: 16180710
[TBL] [Abstract][Full Text] [Related]
14. [Intestinal absorption, organ and tissue distribution of 3H labelled distigmine bromide (true cholinesterase inhibitor) in rats and mice].
Kikuchi H; Sato A; Tomita S; Kano M
Nihon Naika Gakkai Zasshi; 1971 Apr; 60(4):299-304. PubMed ID: 5103723
[No Abstract] [Full Text] [Related]
15. Effect of distigmine bromide on the central cholinergic system.
Nakayama K; Katsu H; Kitazumi K
J Psychopharmacol; 2009 Mar; 23(2):190-3. PubMed ID: 18515453
[TBL] [Abstract][Full Text] [Related]
16. [Effect of distigmine at 5 mg daily in patients with detrusor underactivity].
Sugaya K; Kadekawa K; Onaga T; Ashitomi K; Mukouyama H; Nakasone K; Shimabukuro H; Shimabukuro S; Matayoshi Y; Hokama S; Touyama Y; Nishijima S
Nihon Hinyokika Gakkai Zasshi; 2014 Jan; 105(1):10-6. PubMed ID: 24605581
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic analysis of acetylcholinesterase inhibition by distigmine bromide in rats.
Ito Y; Harada T; Fushimi K; Kagawa Y; Oka H; Nakazawa H; Homma R; Kato Y; Yamada S
Drug Metab Pharmacokinet; 2010; 25(3):254-61. PubMed ID: 20610884
[TBL] [Abstract][Full Text] [Related]
18. Nocturnal hypersalivation caused by distigmine bromide in a patient with multiple system atrophy.
Suzuki K; Miyamoto T; Miyamoto M; Hirata K
Intern Med; 2008; 47(10):983-4. PubMed ID: 18480587
[No Abstract] [Full Text] [Related]
19. [Clinical effects of distigmine bromide (Ubretid), a cholinesterase inhibitor, on micturition disturbance by benign prostatic hypertrophy--comparative study of distigmine bromide and the combination of distigmine bromide and adrenergic blocker].
Katsumi T; Murayama K
Hinyokika Kiyo; 1992 Sep; 38(9):1089-92. PubMed ID: 1384297
[TBL] [Abstract][Full Text] [Related]
20. [Distigmine bromide improves chronic intestinal pseudo-obstruction in a case of MELAS].
Nakae Y; Kishida H; Hakii Y; Koyano S; Suzuki Y; Kuroiwa Y
Rinsho Shinkeigaku; 2007 Apr; 47(4):177-9. PubMed ID: 17511291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]